Drug
Rasburicase
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Cytokine Release Syndrome | 128 | 58.8 | 62.1 | signal |
| 2 | Multiple Organ Dysfunction Syndrome | 87 | 27.2 | 28.2 | signal |
| 3 | Febrile Neutropenia | 202 | 26.6 | 29.0 | signal |
| 4 | Hyperbilirubinaemia | 30 | 25.4 | 25.7 | signal |
| 5 | Disseminated Intravascular Coagulation | 38 | 23.5 | 23.8 | signal |
| 6 | Hypercalcaemia | 23 | 16.3 | 16.4 | signal |
| 7 | Toxic Epidermal Necrolysis | 26 | 15.0 | 15.2 | signal |
| 8 | Hepatocellular Injury | 24 | 14.7 | 14.8 | signal |
| 9 | Hyperkalaemia | 57 | 14.2 | 14.6 | signal |
| 10 | Blood Lactate Dehydrogenase Increased | 26 | 14.2 | 14.4 | signal |
| 11 | Ventricular Fibrillation | 18 | 14.1 | 14.2 | signal |
| 12 | Lymphopenia | 21 | 13.0 | 13.1 | signal |
| 13 | Hypoxia | 52 | 12.9 | 13.2 | signal |
| 14 | Neurotoxicity | 25 | 12.5 | 12.7 | signal |
| 15 | Blood Potassium Increased | 23 | 12.3 | 12.5 | signal |
| 16 | Acute Myeloid Leukaemia | 21 | 11.7 | 11.8 | signal |
| 17 | Respiratory Failure | 91 | 10.9 | 11.2 | signal |
| 18 | Mucosal Inflammation | 32 | 10.7 | 10.8 | signal |
| 19 | Bacteraemia | 14 | 10.4 | 10.4 | signal |
| 20 | Toxic Skin Eruption | 12 | 10.3 | 10.4 | signal |
| 21 | Haematotoxicity | 11 | 10.3 | 10.4 | signal |
| 22 | Encephalopathy | 29 | 10.3 | 10.4 | signal |
| 23 | Posterior Reversible Encephalopathy Syndrome | 11 | 10.1 | 10.1 | signal |
| 24 | Septic Shock | 49 | 9.9 | 10.1 | signal |
| 25 | Clostridium Difficile Colitis | 12 | 9.8 | 9.9 | signal |
| 26 | Cytopenia | 13 | 9.5 | 9.5 | signal |
| 27 | Pancytopenia | 60 | 9.4 | 9.6 | signal |
| 28 | Cardiogenic Shock | 15 | 9.2 | 9.2 | signal |
| 29 | Multi-organ Failure | 18 | 8.9 | 9.0 | signal |
| 30 | Candida Infection | 17 | 8.9 | 8.9 | signal |
| 31 | Neutropenia | 132 | 8.5 | 8.9 | signal |
| 32 | Electrolyte Imbalance | 11 | 8.3 | 8.4 | signal |
| 33 | Acute Kidney Injury | 142 | 8.1 | 8.6 | signal |
| 34 | Sinus Tachycardia | 13 | 8.0 | 8.0 | signal |
| 35 | Sepsis | 102 | 8.0 | 8.3 | signal |
| 36 | Hypocalcaemia | 16 | 7.4 | 7.4 | signal |
| 37 | Subdural Haematoma | 12 | 7.3 | 7.3 | signal |
| 38 | Respiratory Distress | 23 | 7.3 | 7.3 | signal |
| 39 | Hepatic Failure | 25 | 7.2 | 7.3 | signal |
| 40 | Hepatotoxicity | 18 | 7.1 | 7.1 | signal |
| 41 | Blood Creatinine Increased | 52 | 6.9 | 7.1 | signal |
| 42 | Neutrophil Count Decreased | 32 | 6.9 | 7.0 | signal |
| 43 | Metabolic Acidosis | 25 | 6.9 | 6.9 | signal |
| 44 | Blood Test Abnormal | 11 | 6.8 | 6.8 | signal |
| 45 | Nervous System Disorder | 24 | 6.7 | 6.7 | signal |
| 46 | Tachypnoea | 10 | 6.4 | 6.4 | signal |
| 47 | Cholestasis | 14 | 6.4 | 6.4 | signal |
| 48 | Acute Respiratory Failure | 14 | 6.4 | 6.4 | signal |
| 49 | Coagulopathy | 12 | 6.3 | 6.3 | signal |
| 50 | Leukopenia | 36 | 6.3 | 6.4 | signal |
| 51 | Blood Calcium Decreased | 8 | 6.2 | 6.2 | signal |
| 52 | Thrombocytopenia | 79 | 6.2 | 6.3 | signal |
| 53 | Bacterial Infection | 13 | 6.1 | 6.1 | signal |
| 54 | Tubulointerstitial Nephritis | 13 | 6.0 | 6.1 | signal |
| 55 | Splenomegaly | 8 | 5.9 | 6.0 | signal |
| 56 | Product Preparation Error | 14 | 5.9 | 5.9 | signal |
| 57 | Covid-19 Pneumonia | 8 | 5.9 | 5.9 | signal |
| 58 | Chromaturia | 15 | 5.8 | 5.8 | signal |
| 59 | Appendicitis | 6 | 5.6 | 5.6 | signal |
| 60 | Blood Bilirubin Increased | 17 | 5.5 | 5.5 | signal |
| 61 | Renal Tubular Necrosis | 6 | 5.3 | 5.3 | signal |
| 62 | Infusion Related Reaction | 40 | 5.3 | 5.3 | signal |
| 63 | Pericarditis | 10 | 5.2 | 5.2 | signal |
| 64 | Clostridium Difficile Infection | 13 | 5.2 | 5.2 | signal |
| 65 | Bone Marrow Failure | 12 | 5.1 | 5.1 | signal |
| 66 | Gamma-glutamyltransferase Increased | 13 | 5.1 | 5.1 | signal |
| 67 | Drug Resistance | 15 | 5.1 | 5.1 | signal |
| 68 | Petechiae | 6 | 5.0 | 5.0 | signal |
| 69 | Hypomagnesaemia | 8 | 5.0 | 5.0 | signal |
| 70 | Renal Failure | 77 | 5.0 | 5.1 | signal |
| 71 | Staphylococcal Infection | 19 | 5.0 | 5.0 | signal |
| 72 | Lymphocyte Count Decreased | 10 | 4.9 | 4.9 | signal |
| 73 | Aphasia | 17 | 4.9 | 4.9 | signal |
| 74 | Pleural Effusion | 34 | 4.9 | 4.9 | signal |
| 75 | Cardio-respiratory Arrest | 23 | 4.8 | 4.8 | signal |
| 76 | Fluid Overload | 8 | 4.7 | 4.7 | signal |
| 77 | Skin Disorder | 18 | 4.7 | 4.7 | signal |
| 78 | Renal Failure Acute | 23 | 4.7 | 4.7 | signal |
| 79 | Upper Gastrointestinal Haemorrhage | 9 | 4.6 | 4.7 | signal |
| 80 | Circulatory Collapse | 9 | 4.6 | 4.6 | signal |
| 81 | Sinus Bradycardia | 5 | 4.5 | 4.5 | signal |
| 82 | Plasma Cell Myeloma | 20 | 4.5 | 4.5 | signal |
| 83 | Acute Respiratory Distress Syndrome | 9 | 4.4 | 4.4 | signal |
| 84 | Polyneuropathy | 6 | 4.4 | 4.4 | signal |
| 85 | Dialysis | 7 | 4.3 | 4.3 | signal |
| 86 | Product Prescribing Issue | 10 | 4.3 | 4.3 | signal |
| 87 | White Blood Cell Count Decreased | 53 | 4.3 | 4.3 | signal |
| 88 | Folliculitis | 5 | 4.2 | 4.2 | signal |
| 89 | Cardiac Arrest | 40 | 4.2 | 4.3 | signal |
| 90 | Cytomegalovirus Infection | 8 | 4.2 | 4.2 | signal |
| 91 | Unresponsive To Stimuli | 12 | 4.1 | 4.1 | signal |
| 92 | Disease Progression | 55 | 4.1 | 4.1 | signal |
| 93 | Transaminases Increased | 10 | 3.9 | 3.9 | signal |
| 94 | Obstructive Airways Disorder | 5 | 3.9 | 3.9 | signal |
| 95 | Lung Infection | 7 | 3.9 | 3.9 | signal |
| 96 | Pneumonitis | 11 | 3.5 | 3.6 | signal |
| 97 | Hospice Care | 4 | 3.5 | 3.5 | signal |
| 98 | Stevens-johnson Syndrome | 9 | 3.5 | 3.5 | signal |
| 99 | Pneumocystis Jirovecii Pneumonia | 4 | 3.5 | 3.5 | signal |
| 100 | Agranulocytosis | 7 | 3.3 | 3.3 | signal |
| 101 | Rebound Effect | 4 | 3.1 | 3.1 | no signal |
| 102 | Full Blood Count Decreased | 7 | 3.0 | 3.0 | signal |
| 103 | Neoplasm Progression | 12 | 3.0 | 3.0 | signal |
| 104 | Myelosuppression | 11 | 2.8 | 2.8 | signal |
| 105 | Lactic Acidosis | 9 | 2.4 | 2.4 | signal |
| 106 | Malignant Neoplasm Progression | 24 | 2.1 | 2.1 | signal |
| 107 | Synovitis | 3 | 1.4 | 1.4 | no signal |
| 108 | Product Storage Error | 13 | 1.3 | 1.3 | no signal |
| 109 | Accidental Exposure To Product | 10 | 0.9 | 0.9 | no signal |